Insulin-like growth factor (IGF) binding protein 3 (IGFBP3) is a major carrier of IGF1 and IGF2 in circulation and IGFBP3 levels are reduced in breast cancer patients, giving rise to higher free IGF1 levels and poor prognosis (25,26). The gene discussed is IGF2; the disease is breast carcinoma.